 vitro and in animal studies to deliver an essentially constant dose of a period of 6 months or longer. The rate-controlling membrane is a hydrogel. Specific goals of the study are: (a) determine whether these histrelin-delivering implants can be used in humans; (b) ascertain the dose of hist
vitro and in animal studies to deliver an essentially constant venereal disease of a time period of 6 months or longer. The rate - control membrane is a hydrogel. Specific goals of the study are: (a) specify whether these histrelin - delivering implants can be use in humans; (b) ascertain the acid of hist
 vihro and in animal studier to deliver an essentmally cknstant aose of a period of 6 months lr longtg. The rate-controlling membrane is a hyerogtl. Specific goals of the study zve: (a) bevermine whether these hisdrelin-deliveritg ilplants can be used in humans; (b) ascqrtain yhf dose of hist
vitro and in animal studies to deliver constant of a of 6 months is hydrogel. Specific goals the study are: determine whether these histrelin-delivering implants can used in humans; (b) ascertain the dose of hist
 vitro and in animal studies to Deliver an eSsentIalLy cOnStanT dosE of a period of 6 moNThs oR longer. The rate-controllIng meMbRAne iS A hYdrogEl. SpeciFIc GOAls Of ThE stUdY ArE: (a) detErmIne whetHer these hiStrElIn-delivering IMpLants can be UseD in humans; (b) asCerTain thE dOse OF hist
 vitro and in animal studi es to deli ver a n e sse nt iall y co nstant dose of a pe riod of 6 months or lo nger.  T h e ra t e- contr ollingm em b r ane  i sa h yd r og el. S pec ific go als of the  st ud y are: (a) d e te rmine whet her  these histr eli n-deli ve rin g  impl ant s can  be us e d in h umans; (b )a scerta i n the d o s eof h ist
 vitro_and in_animal studies to deliver_an essentially_constant_dose of_a_period of 6_months or longer._The rate-controlling membrane is_a hydrogel. Specific_goals_of the study are: (a) determine whether these histrelin-delivering implants can be used in_humans;_(b) ascertain_the_dose_of hist